Detrimental effects of adolescent escalating low-dose Δ

adolescent biochemical pharmacology cannabinoid cognition neurogenesis neuronal plasticity translational pharmacology

Journal

British journal of pharmacology
ISSN: 1476-5381
Titre abrégé: Br J Pharmacol
Pays: England
ID NLM: 7502536

Informations de publication

Date de publication:
04 2021
Historique:
received: 12 10 2020
revised: 27 12 2020
accepted: 18 01 2021
pubmed: 27 1 2021
medline: 6 7 2021
entrez: 26 1 2021
Statut: ppublish

Résumé

Adolescent cannabis use is associated with adult psychopathology. When Δ Adolescent male Sprague-Dawley rats were treated with escalating low-dose of THC. In adulthood, they were evaluated for their spontaneous locomotion, sensorimotor gating, higher order and spatial cognitive functions. Dopaminergic activity and cannabinoid receptor expression were measured in distinct brain regions. Hippocampal neurogenic activity of neural stem cells was determined and protein levels of neuroplasticity-related biomarkers were quantified. Adolescent low-dose THC exposure increased spontaneous open-field activity, without affecting prepulse inhibition and attentional set-shifting performance. Region-specific dopaminergic alterations and CB Our findings reveal the adverse impact of adolescent low-dose THC on the psychomotor profile, dopaminergic neurotransmission, compensatory cannabinoid receptor response, cognition-related neurobiological and behavioural functions. Our adolescent low-dose THC animal model does not induce tangible psychotic-like effects, such as those reported in high-dose THC studies, but it impairs cognitive functions and points to hippocampal vulnerability and disrupted neurogenesis.

Sections du résumé

BACKGROUND AND PURPOSE
Adolescent cannabis use is associated with adult psychopathology. When Δ
EXPERIMENTAL APPROACH
Adolescent male Sprague-Dawley rats were treated with escalating low-dose of THC. In adulthood, they were evaluated for their spontaneous locomotion, sensorimotor gating, higher order and spatial cognitive functions. Dopaminergic activity and cannabinoid receptor expression were measured in distinct brain regions. Hippocampal neurogenic activity of neural stem cells was determined and protein levels of neuroplasticity-related biomarkers were quantified. Adolescent low-dose THC exposure increased spontaneous open-field activity, without affecting prepulse inhibition and attentional set-shifting performance. Region-specific dopaminergic alterations and CB
KEY RESULTS
Our findings reveal the adverse impact of adolescent low-dose THC on the psychomotor profile, dopaminergic neurotransmission, compensatory cannabinoid receptor response, cognition-related neurobiological and behavioural functions.
CONCLUSION AND IMPLICATIONS
Our adolescent low-dose THC animal model does not induce tangible psychotic-like effects, such as those reported in high-dose THC studies, but it impairs cognitive functions and points to hippocampal vulnerability and disrupted neurogenesis.

Identifiants

pubmed: 33496341
doi: 10.1111/bph.15394
doi:

Substances chimiques

Dcx protein, rat 0
Doublecortin Protein 0
Dronabinol 7J8897W37S

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1722-1736

Informations de copyright

© 2021 The British Pharmacological Society.

Références

Abboussi, Ο., Tazi, A., Paizanis, E., & El Ganouni, S. (2014). Chronic exposure to WIN55,212-2 affects more potently spatial learning and memory in adolescents than in adult rats via a negative action on dorsal hippocampal neurogenesis. Pharmacology, Biochemistry and Behavior, 120, 95-102. https://doi.org/10.1016/j.pbb.2014.02.014
Abela, A. R., Rahbarnia, A., Wood, S., Lê, A. D., & Fletcher, P. J. (2019). Adolescent exposure to Δ9-tetrahydrocannabinol delays acquisition of paired-associates learning in adulthood. Psychopharmacology, 236(6), 1875-1886. https://doi.org/10.1007/s00213-019-5171-1
Abush, H., & Akirav, I. (2013). Cannabinoids ameliorate impairments induced by chronic stress to synaptic plasticity and short-term memory. Neuropsychopharmacology, 38, 1521-1534. https://doi.org/10.1038/npp.2013.51
Alexander, S. P. H., Christopoulos, A., Davenport, A. P., Kelly, E., Mathie, A., Peters, J. A., Veale, E. L., Armstrong, J. F., Faccenda, E., Harding, S. D., Pawson, A. J., Sharman, J. L., Southan, C., Davies, J. A., & Collaborators, C. G. T. P. (2019). The concise guide to pharmacology 2019/20: G protein-coupled receptors. British Journal of Pharmacology, 176, S21-S141. https://doi.org/10.1111/bph.14748
Alexander, S. P. H., Fabbro, D., Kelly, E., Mathie, A., Peters, J. A., Veale, E. L., Armstrong, J. F., Faccenda, E., Harding, S. D., Pawson, A. J., Sharman, J. L., Southan, C., Davies, J. A., & Collaborators, C. G. T. P. (2019a). The concise guide to pharmacology 2019/20: Enzymes. British Journal of Pharmacology, 176, S297-S396. https://doi.org/10.1111/bph.14752
Alexander, S. P. H., Fabbro, D., Kelly, E., Mathie, A., Peters, J. A., Veale, E. L., Armstrong, J. F., Faccenda, E., Harding, S. D., Pawson, A. J., Sharman, J. L., Southan, C., Davies, J. A., & Collaborators, C. G. T. P. (2019b). The concise guide to pharmacology 2019/20: Catalytic receptors. British Journal of Pharmacology, 176, S247-S296. https://doi.org/10.1111/bph.14751
Alexander, S. P. H., Kelly, E., Mathie, A., Peters, J. A., Veale, E. L., Armstrong, J. F., Faccenda, E., Harding, S. D., Pawson, A. J., Sharman, J. L., Southan, C., Davies, J. A., & Collaborators, C. G. T. P. (2019). The concise guide to pharmacology 2019/20: Transporters. British Journal of Pharmacology, 176(Suppl 1), S397-S493. https://doi.org/10.1111/bph.14753
Alexander, S. P. H., Roberts, R. E., Broughton, B. R. S., Sobey, C. G., George, C. H., Stanford, S. C., Cirino, G., Docherty, J. R., Giembycz, M. A., Hoyer, D., Insel, P. A., Izzo, A. A., Ji, Y., MacEwan, D. J., Mangum, J., Wonnacott, S., & Ahluwalia, A. (2018). Goals and practicalities of immunoblotting and immunohistochemistry: A guide for submission to the British Journal of Pharmacology. British Journal of Pharmacology, 175, 407-411. https://doi.org/10.1111/bph.14112
Bagot, K. S., Milin, R., & Kaminer, Y. (2015). Adolescent initiation of cannabis use and early-onset psychosis. Substance Abuse, 36(4), 524-533. https://doi.org/10.1080/08897077.2014.995332
Bezu, M., Maliković, J., Kristofova, M., Engidawork, E., Höger, H., Lubec, G., & Korz, V. (2017). Spatial working memory in male rats: Pre-experience and task dependent roles of dopamine D1- and D2-like receptors. Frontiers in Behavioral Neuroscience, 11(196), 1-8. https://doi.org/10.3389/fnbeh.2017.00196
Birrell, J. M., & Brown, V. J. (2000). Medial frontal cortex mediates perceptual attentional set shifting in the rat. Journal of Neuroscience, 20(11), 4320-4324. https://doi.org/10.1523/JNEUROSCI.20-11-04320.2000
Bissonette, G. B., & Roesch, M. R. (2017). Neurophysiology of rule switching in the corticostriatal circuit. Neuroscience, 345, 64-76. https://doi.org/10.1016/j.neuroscience.2016.01.062
Calabrese, E. J., & Rubio-Casillas, A. (2018). Biphasic effects of THC in memory and cognition. European Journal of Clinical Investigation, 48(5), e12920. https://doi.org/10.1111/eci.12920
Casadio, P., Fernandes, C., Murray, R. M., & Di Forti, M. (2011). Cannabis use in young people: The risk for schizophrenia. Neuroscience and Biobehaval Reviews, 35(8), 1779-1787. https://doi.org/10.1016/j.neubiorev.2011.04.007
Cavoy, A., & Delacour, J. (1993). Spatial but not object recognition is impaired by aging in rats. Physiology and Behavior, 53, 527-530. https://doi.org/10.1016/0031-9384(93)90148-9
Coffey, C., & Patton, G. C. (2016). Cannabis use in adolescence and young adulthood: A review of findings from the Victorian Adolescent Health Cohort Study. Cananadian Journal of Psychiatry, 61(6), 318-327. https://doi.org/10.1177/0706743716645289
Curtis, M. J., Alexander, S., Cirino, G., Docherty, J. R., George, G. H., Giembycz, M. A., Hoyer, D., Insel, P. A., Izzo, A. A., Ji, Y., MacEwan, D. J., Sobey, C. G., Stanford, S. C., Teixeira, M. M., Wonnacott, S., & Ahluwalia, A. (2018). Experimental design and analysis and their reporting II: Updated and simplified guidance for authors and peer reviewers. British Journal of Pharmacology, 175(7), 987-993. https://doi.org/10.1111/bph.14153
Dalla, C., Antoniou, K., Kokras, N., Drossopoulou, G., Papathanasiou, G., Bekris, S., Daskas, S., & Papadopoulo-Daifoti, Z. (2008). Sex differences in the effects of two stress paradigms on dopaminergic neurotransmission. Physiology and Behavior, 93(3), 595-605. https://doi.org/10.1016/j.physbeh.2007.10.020
Duszkiewicz, A. J., McNamara, C. G., Takeuchi, T., & Genzel, L. (2019). Novelty and dopaminergic modulation of memory persistence: A tale of two systems. Trends in Neurosciences, 42(2), 102-114. https://doi.org/10.1016/j.tins.2018.10.002
Ennaceur, A. (1998). Effects of lesions of the substantia innominata/ventral pallidum, globus pallidus and medial septum on rat's performance in object-recognition and radial-maze tasks: Physostigmine and amphetamine treatments. Pharmacological Research, 38, 251-263. https://doi.org/10.1006/phrs.1998.0361
Fenoglio, K. A., Brunson, K. L., & Baram, T. Z. (2006). Hippocampal neuroplasticity induced by early-life stress: Functional and molecular aspects. Frontiers in Neuroendocrinology, 27(2), 180-192. https://doi.org/10.1016/j.yfrne.2006.02.001
Geyer, M., Krebs-Thomson, K., Braff, D. L., & Swerdlow, N. R. (2001). Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: A decade in review. Psychopharmacology, 156(2-3), 117-154. https://doi.org/10.1007/s002130100811
Goldman-Rakic, P. S., Muly, E. C., & Williams, G. V. (2000). D(1) receptors in prefrontal cells and circuits. Brain Research. Brain Research Reviews, 31(2-3), 295-301. https://doi.org/10.1016/S0165-0173(99)00045-4
Gomes, F. V., Guimarães, F. S., & Grace, A. A. (2015). Effects of pubertal cannabinoid administration on attentional set-shifting and dopaminergic hyper-responsivity in a developmental disruption model of schizophrenia. The International Journal of Neuropsychopharmacology, 18(2), pyu018.
Harte, L. C., & Dow-Edwards, D. (2010). Sexually dimorphic alterations in locomotion and reversal learning after adolescent tetrahydrocannabinol exposure in the rat. Neurotoxicology and Teratology, 32(5), 515-524. https://doi.org/10.1016/j.ntt.2010.05.001
Jones, C. E., Navis, T. M., Teutsch, P., Opel, R. A., & Lim, M. M. (2019). Acoustic prepulse inhibition in male and female prairie voles: Implications for models of neuropsychiatric illness. Behavoral and Brain Research, 360, 298-302. https://doi.org/10.1016/j.bbr.2018.12.022
Katsidoni, V., Kastellakis, A., & Panagis, G. (2013). Biphasic effects of Δ9-tetrahydrocannabinol on brain stimulation reward and motor activity. International Journal of Neuropsychopharmacology, 216(10), 2273-2284.
Kokras, N., Pastromas, N., Papasava, D., de Bournonville, C., Cornil, C. A., & Dalla, C. (2018). Sex differences in behavioral and neurochemical effects of gonadectomy and aromatase inhibition in rats. Psychoneuroendocrinology, 87, 93-107. https://doi.org/10.1016/j.psyneuen.2017.10.007
Koutmani, Y., Gampierakis, I. A., Polissidis, A., Ximerakis, M., Koutsoudaki, P. N., Polyzos, A., Agrogiannis, G., Karaliota, S., Thomaidou, D., Rubin, L. L., Politis, P. K., & Karalis, K. P. (2019). CRH promotes the neurogenic activity of neural stem cells in the adult hippocampus. Cell Reports, 29(4), 932-945. https://doi.org/10.1016/j.celrep.2019.09.037
Lee, T. T., Wainwright, S. R., Hill, M. N., Galea, L. A., & Gorzalka, B. B. (2014). Sex, drugs, and adult neurogenesis: Sex-dependent effects of escalating adolescent cannabinoid exposure on adult hippocampal neurogenesis, stress reactivity, and amphetamine sensitization. Hippocampus, 24(3), 280-292. https://doi.org/10.1002/hipo.22221
Lilley, E., Stanford, S. C., Kendall, D. E., Alexander, S. P., Cirino, G., Docherty, J. R., George, C. H., Insel, P. A., Izzo, A. A., Ji, Y., Panettieri, R. A., Sobey, C. G., Stefanska, B., Stephens, G., Teixeira, M., & Ahluwalia, A. (2020). ARRIVE 2.0 and the British Journal of Pharmacology: Updated guidance for 2020. British Journal of Pharmacology, 3611-3616. https://bpspubs.onlinelibrary.wiley.com/doi/full/10.1111/bph.15178
Llorente-Berzal, A., Puighermanal, E., Burokas, A., Ozaita, A., Maldonado, R., Marco, E. M., & Viveros, M. P. (2013). Sex-dependent psychoneuroendocrine effects of THC and MDMA in an animal model of adolescent drug consumption. PLoS One, 8, 11e78386.
López-Gallardo, M., López-Rodríguez, A. B., Llorente-Berzal, Á., Rotllant, D., Mackie, K., Armario, A., Nadal, R., & Viveros, M. P. (2012). Maternal deprivation and adolescent cannabinoid exposure impact hippocampal astrocytes, CB1 receptors and brain-derived neurotrophic factor in a sexually dimorphic fashion. Neuroscience, 1(204), 90-103.
Maj, P. F., Collu, M., Fadda, P., Cattaneo, A., Racagni, G., & Riva, M. A. (2007). Long-term reduction of brain-derived neurotrophic factor levels and signaling impairment following prenatal treatment with the cannabinoid receptor 1 receptor agonist (R)-(+)-[2,3-dihydro-5-methyl-3-(4-morpholinyl-methyl) pyrrolo[1,2,3-de]-1,4-benzoxazin-6-yl]-1- naphthalenylmethanone. European Journal of Neuroscience, 25(11), 3305-3311.
Markou, A., Chiamulera, C., Geyer, M. A., Tricklebank, M., & Steckler, T. (2009). Removing obstacles in neuroscience drug discovery: The future path for animal models. Neuropsychopharmacology, 34(1), 74-89. https://doi.org/10.1038/npp.2008.173
Marsicano, G., & Lutz, B. (1999). Expression of the cannabinoid receptor CB1 in distinct neuronal subpopulations in the adult mouse forebrain. European Journal of Neuroscience, 11(12), 4213-4225. https://doi.org/10.1046/j.1460-9568.1999.00847.x
Moore, N. L., Greenleaf, A. L., Acheson, S. K., Wilson, W. A., Swartzwelder, H. S., & Kuhn, C. M. (2010). Role of cannabinoid receptor type 1 desensitization in greater tetrahydrocannabinol impairment of memory in adolescent rats. The Journal of Pharmacology and Experimetnal Therapeutics, 335, 294-301. https://doi.org/10.1124/jpet.110.169359
Moreno-Castilla, P., Pérez-Ortega, R., Violante-Soria, V., Balderas, I., & Bermúdez-Rattoni, F. (2017). Hippocampal release of dopamine and norepinephrine encodes novel contextual information. Hippocampus, 27(5), 547-557. https://doi.org/10.1002/hipo.22711
Percie du Sert, N., Hurst, V., Ahluwalia, A., Alam, S., Avey, M. T., Baker, M., Browne, W. J., Clark, A., Cuthill, I. C., Dirnagl, U., Emerson, M., Garner, P., Holgate, S. T., Howells, D. W., Karp, N. A., Lazic, S. E., Lidster, K., Maccallum, C. J., Macleod, M., … Würbel, H. (2020). The ARRIVE guidelines 2.0: updated guidelines for reporting animal research. PLoS Biology, 18(7), e3000410. https://doi.org/10.1371/journal.pbio.3000410
Perez, S. M., & Lodge, D. J. (2019). Adolescent stress contributes to aberrant dopamine signaling in a heritable rodent model of susceptibility. Progress in Neuropsychopharmacology and Biological Psychiatry, 95, 1-18. https://doi.org/10.1016/j.pnpbp.2019.109701
Pitsikas, N., & Boultadakis, A. (2009). Pre-training administration of anesthetic ketamine differentially affects rats' spatial and non-spatial recognition memory. Neuropharmacology, 57, 1-7. https://doi.org/10.1016/j.neuropharm.2009.03.015
Polissidis, A., Chouliara, O., Galanopoulos, A., Rentesi, G., Dosi, M., Hyphantis, T., Marselos, M., Papadopoulou-Daifoti, Z., Nomikos, G. G., Spyraki, C., Tzavara, E. T., & Antoniou, K. (2010). Individual differences in the effects of cannabinoids on motor activity, dopaminergic activity and DARPP-32 phosphorylation in distinct regions of the brain. International Journal of Neuropsychopharmacology, 13, 1175-1191. https://doi.org/10.1017/S1461145709991003
Polissidis, A., Galanopoulos, A., Naxakis, G., Papahatjis, D., Papadopoulou-Daifoti, Z., & Antoniou, K. (2013). The cannabinoid CB1 receptor biphasically modulates motor activity and regulates dopamine and glutamate release region dependently. International Journal of Neuropsychopharmacology, 16, 393-403. https://doi.org/10.1017/S1461145712000156
Poulia, N., Delis, F., Brakatselos, C., Lekkas, P., Kokras, N., Dalla, C., & Antoniou, K. (2020). Escalating low-dose Δ9-tetrahydrocannabinol exposure during adolescence induces differential behavioral and neurochemical effects in male and female adult rats. European Journal of Neuroscience, 52(1), 2681-2693. https://doi.org/10.1111/ejn.14598
Powell, C. M., & Miyakawa, T. (2006). Schizophrenia-relevant behavioral testing in rodent models: A uniquely human disorder? Biological Psychiatry, 59(12), 1198-1207. https://doi.org/10.1016/j.biopsych.2006.05.008
Ragozzino, M. E. (2007). The contribution of the medial prefrontal cortex, orbitofrontal cortex, and dorsomedial striatum to behavioral flexibility. Annual NY Academy of Science, 1121, 355-375. https://doi.org/10.1196/annals.1401.013
Renard, J., Rosen, L. G., Loureiro, M., De Oliveira, C., Schmid, S., Rushlow, W. J., & Laviolette, S. R. (2016). Adolescent cannabinoid exposure induces a persistent sub-cortical hyper-dopaminergic state and associated molecular adaptations in the prefrontal cortex. Cerebral Cortex, 27(2), 1297-1310.
Renard, J., Rushlow, W. J., & Laviolette, S. R. (2016). What can rats tell us about adolescent cannabis exposure? Insights from preclinical research. Canadian Journal of Psychiatry, 61, 328-334. https://doi.org/10.1177/0706743716645288
Renard, J., Szkudlarek, H. J., Kramar, C. P., Jobson, C. E. L., Moura, K., Rushlow, W. J., & Laviolette, S. R. (2017). Adolescent THC exposure causes enduring prefrontal cortical disruption of GABAergic inhibition and dysregulation of sub-cortical dopamine function. Scientific Reports, 7(11420), 1-14. https://doi.org/10.1038/s41598-017-11645-8
Rubino, T., Realini, N., Braida, D., Guidi, S., Capurro, V., Viganò, D., Guidali, C., Pinter, M., Sala, M., Bartesaghi, R., & Parolaro, D. (2009). Changes in hippocampal morphology and neuroplasticity induced by adolescent THC treatment are associated with cognitive impairment in adulthood. Hippocampus, 19(8), 763-772. https://doi.org/10.1002/hipo.20554
Rubino, T., Vigano, D., Realini, N., Guidali, C., Braida, D., Capurro, V., Castiglioni, C., Cherubino, F., Romualdi, P., Candeletti, S., Sala, M., & Parolaro, D. (2008). Chronic Δ9-tetrahydrocannabinol during adolescence provokes sex-dependent changes in the emotional profile in adult rats: Behavioral and biochemical correlates. Neuropsychopharmacology, 33, 2760-2771. https://doi.org/10.1038/sj.npp.1301664
Santos, C. M., Peres, F. F., Diana, M. C., Justi, V., Suiama, M. A., Santana, M. G., & Abílio, V. C. (2016). Peripubertal exposure to environmental enrichment prevents schizophrenia-like behaviors in the SHR strain animal model. Schizophrenia Research, 176(2-3), 552-559. https://doi.org/10.1016/j.schres.2016.06.006
Seamans, J. K., & Yang, C. R. (2004). The principal features and mechanisms of dopamine modulation in the prefrontal cortex. Progress in Neurobiology, 74(1), 1-58. https://doi.org/10.1016/j.pneurobio.2004.05.006
Shen, E. Y., Ali, S. F., & Meyer, J. S. (2011). Chronic administration of THC prevents the behavioral effects of intermittent adolescent MDMA administration and attenuates MDMA-induced hyperthermia and neurotoxicity in rats. Neuropharmacolology, 61, 1183-1192. https://doi.org/10.1016/j.neuropharm.2011.07.002
Silins, E., Horwood, L. J., Patton, G. C., Fergusson, D. M., Olsson, C. A., Hutchinson, D. M., Spry, E., Toumbourou, J. W., Degenhardt, L., Swift, W., Coffey, C., Tait, R. J., Letcher, P., Copeland, J., Mattick, R. P., Cannabis Cohorts Research Consortium, & Mattrick, R. P. (2014). Young adult sequelae of adolescent cannabis use: An integrative analysis. Lancet Psychiatry, 1(4), 286-293. https://doi.org/10.1016/S2215-0366(14)70307-4
Silva, L., Black, R., Michaelides, M., Hurd, Y. L., & Dow-Edwards, D. (2016). Sex and age specific effects of Δ-9-tetrahydrocannabinol during the periadolescent period in the rat: The unique susceptibility of the prepubescent animal. Neurotoxicology and Teratology, 58, 88-100. https://doi.org/10.1016/j.ntt.2016.02.005
Silva-Peña, D., Rivera, P., Alén, F., Vargas, A., Rubio, L., García-Marchena, N., Pavón, F. J., Serrano, A., de Fonseca, F. R., & Suarez, Y. (2019). Oleoylethanolamide modulates BDNF-ERK signaling and neurogenesis in the hippocampi of rats exposed to Δ9-THC and ethanol binge drinking during adolescence. Frontiers in Molecular Neuroscience, 12(96), 1-15. https://doi.org/10.3389/fnmol.2019.00096
Sim-Selley, L. J., Schechter, N. S., Rorrer, W. K., Dalton, G. D., Hernandez, J., Martin, B. R., & Selley, D. E. (2006). Prolonged recovery rate of CB1 receptor adaptation after cessation of long-term cannabinoid administration. Molecular Pharmacology, 70(3), 986-996. https://doi.org/10.1124/mol.105.019612
Steel, R. W., Miller, J. H., Sim, D. A., & Day, D. J. (2014). Δ-9-tetrahydrocannabinol disrupts hippocampal neuroplasticity and neurogenesis in trained, but not untrained adolescent Sprague-Dawley rats. Brain Research, 1548, 12-19. https://doi.org/10.1016/j.brainres.2013.12.034
Swerdlow, N. R., Braff, D. L., Masten, V. L., & Geyer, M. A. (1990). Schizophrenic-like sensorimotor gating abnormalities in rats following dopamine infusion into the nucleus accumbens. Psychopharmacology, 101(3), 414-420. https://doi.org/10.1007/BF02244063
Tait, S., Chase, A., & Brown, V. (2014). Attentional set-shifting in rodents: A review of behavioural methods and pharmacological results. Current Pharmacological Design, 20(31), 5046-5059. https://doi.org/10.2174/1381612819666131216115802
Taylor, M., Collin, S. M., Munafò, M. R., MacLeod, J., Hickman, M., & Heron, J. (2017). Patterns of cannabis use during adolescence and their association with harmful substance use behaviour: Findings from a UK birth cohort. Journal of Epidemiological Community Health, 71(8), 764-770. https://doi.org/10.1136/jech-2016-208503
Van den Buuse, M. (2010). Modeling the positive symptoms of schizophrenia in genetically modified mice: Pharmacology and methodology aspects. Schizophrenia Bulletin, 36(2), 246-270. https://doi.org/10.1093/schbul/sbp132
Vorhees, C., & Williams, M. (2006). Morris water maze: Procedures for assessing spatial and related forms of learning and memory. Nature Protocols, 1(2), 848-858. https://doi.org/10.1038/nprot.2006.116
Wan, F. J., & Swerdlow, N. R. (1996). Sensorimotor gating in rats is regulated by different dopamine-glutamate interactions in the nucleus accumbens core and shell subregions. Brain Research, 722(1-2), 168-176. https://doi.org/10.1016/0006-8993(96)00209-0
Zamberletti, E., Beggiato, S., Steardo, L., Prini, P., Antonelli, T., Ferraro, L., Rubino, T., & Parolaro, D. (2014). Alterations of prefrontal cortex GABAergic transmission in the complex psychotic-like phenotype induced by adolescent Δ-9-tetrahydrocannabinol exposure in rats. Neurobiololy of Disease, 63, 35-47. https://doi.org/10.1016/j.nbd.2013.10.028
Zamberletti, E., Gabaglio, M., Prini, P., Rubino, T., & Parolaro, D. (2015). Cortical neuroinflammation contributes to long-term cognitive dysfunctions following adolescent Δ-9-tetrahydrocannabinol treatment in female rats. European Neuropsychopharmacology, 25(12), 2404-2415. https://doi.org/10.1016/j.euroneuro.2015.09.021

Auteurs

Nafsika Poulia (N)

Department of Pharmacology, Faculty of Medicine, School of Health Sciences, University of Ioannina, Ioannina, Greece.

Foteini Delis (F)

Department of Pharmacology, Faculty of Medicine, School of Health Sciences, University of Ioannina, Ioannina, Greece.

Charalampos Brakatselos (C)

Department of Pharmacology, Faculty of Medicine, School of Health Sciences, University of Ioannina, Ioannina, Greece.

Alexia Polissidis (A)

Center of Clinical, Experimental Surgery and Translational Research, Biomedical Research Foundation of the Academy of Athens, Athens, Greece.

Yassemi Koutmani (Y)

Center of Clinical, Experimental Surgery and Translational Research, Biomedical Research Foundation of the Academy of Athens, Athens, Greece.
Center of Basic Research, Biomedical Research Foundation of the Academy of Athens, Athens, Greece.

Nikolaos Kokras (N)

Department of Pharmacology, Faculty of Medicine, National and Kapodistrian University of Athens, Athens, Greece.
First Department of Psychiatry, Faculty of Medicine, National and Kapodistrian University of Athens, Athens, Greece.

Christina Dalla (C)

Department of Pharmacology, Faculty of Medicine, National and Kapodistrian University of Athens, Athens, Greece.

Panagiotis K Politis (PK)

Center of Basic Research, Biomedical Research Foundation of the Academy of Athens, Athens, Greece.

Katerina Antoniou (K)

Department of Pharmacology, Faculty of Medicine, School of Health Sciences, University of Ioannina, Ioannina, Greece.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH